Skip to main content
SYNAIRGEN PLC logo

SYNAIRGEN PLC — Investor Relations & Filings

Ticker · SNG ISIN · GB00B0381Z20 LEI · 213800IMMTOPPDF8HD24 IL Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2022-12-01 Board/Management Inform…
Country GB United Kingdom
Listing IL SNG

About SYNAIRGEN PLC

https://www.synairgen.com/

Synairgen PLC is a clinical-stage biotechnology company focused on the discovery and development of treatments for severe respiratory diseases. The company's primary focus is its lead investigative candidate, SNG001, an inhaled formulation of interferon-beta (IFN-β). SNG001 is being developed as a potential host-directed, broad-spectrum antiviral therapy delivered directly to the lungs. This approach aims to treat hospitalized patients with severe viral lung infections caused by a range of pathogens, including influenza, RSV, and coronaviruses.

Recent filings

Filing Released Lang Actions
Board Changes
Board/Management Information Classification · 99% confidence The document is an official announcement dated December 1, 2022, from Synairgen plc, identified by the RNS Number (1397I) and the closing statement referencing RNS, the news service of the London Stock Exchange. The core content explicitly states: 'Board Changes' and details the appointment of a new independent Non-Executive Director (Amanda Radford) and the retirement of another director (Iain Buchanan). This directly corresponds to the definition of Board/Management Information.
2022-12-01 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 5810F'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the FCA as a Primary Information Provider. This type of short, specific regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS). It is not an announcement of a report (RPA), but a direct regulatory notice.
2022-11-07 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 5800F' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational update related to trading mechanisms. This type of short, specific regulatory announcement that doesn't fit into the major reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as it is distributed via the RNS system.
2022-11-07 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This clearly identifies the document as a general regulatory announcement disseminated via the RNS system, which aligns with the 'Regulatory Filings' category, used as a fallback for miscellaneous regulatory announcements that don't fit specific categories like Director's Dealing or Dividend Notices. Given the nature of the content (a trading halt/extension notice), RNS is the most appropriate classification.
2022-11-03 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a routine operational update related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Given its nature as a short, specific regulatory/exchange operational notice that doesn't fit other specific categories (like DIRS, DIV, or MANG), it falls best under the general regulatory announcement category.
2022-11-03 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 6184D'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback.
2022-10-20 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.